The evidence for dietary prevention and treatment of cardiovascular disease

被引:223
|
作者
Van Horn, Linda [1 ]
McCoin, Mikelle [2 ,3 ]
Kris-Etherton, Penny M. [4 ]
Burke, Frances [5 ]
Carson, Jo Ann S. [6 ]
Champagne, Catherine M. [7 ]
Karmally, Wahida [8 ]
Sikand, Geeta [9 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Fac Dev, Chicago, IL 60611 USA
[2] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA
[3] Univ Calif Berkeley, Berkeley, CA 94720 USA
[4] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA
[5] Univ Penn Hlth Syst, Sch Med, Prevent Canc Program, Nutr Educ & Prevent Program, Philadelphia, PA USA
[6] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA
[7] Pennington Biomed Res Ctr, Baton Rouge, LA USA
[8] Columbia Univ, Med Ctr, Irving Ctr Clin Res, New York, NY USA
[9] Univ Calif Irvine, Coll Med, Div Cardiol, Irvine, CA 92717 USA
关键词
D O I
10.1016/j.jada.2007.10.050
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
During the past few decades numerous studies have reported the atherogenic potential of saturated fatty acids, trans-fatty acids, and cholesterol, and beneficial effects of fiber, phytostanols/phytosterols, n-3 fatty acids, a Mediterranean diet, and other plant-based approaches. The purpose of this article is to provide a comprehensive and systematic review of the evidence associated with key dietary factors and risk of cardiovascular disease-an umbrella term encompassing diseases that affect the heart and blood vessels, including coronary heart disease, coronary artery disease, dyslipidemia, and hypertension-in conjunction with the work of the American Dietetic Association Evidence Analysis Library review on diet and lipids, updated with new evidence from the past 2 years. The criteria used and results cited provide scientific rationale for food and nutrition professionals and other health professionals for counseling patients. Details of these searches are available within the American Dietetic Association Evidence Analysis Library online (http://adaevidencelibrary.com). Potential mechanisms and needs for future research are summarized for each relevant nutrient, food, or food component.
引用
收藏
页码:287 / 331
页数:45
相关论文
共 50 条
  • [21] Dietary isoflavones in the prevention of cardiovascular disease - A molecular perspective
    Rimbach, Gerald
    Boesch-Saadatmandi, Christine
    Frank, Jan
    Fuchs, Dagmar
    Wenzel, Uwe
    Daniel, Hannelore
    Hall, Wendy L.
    Weinberg, Peter D.
    FOOD AND CHEMICAL TOXICOLOGY, 2008, 46 (04) : 1308 - 1319
  • [22] Cardiovascular disease prevention in women: Impact of dietary interventions
    Hoekstra, Tiny
    Beulens, Joline W. J.
    van der Schouw, Yvonne T.
    MATURITAS, 2009, 63 (01) : 20 - 27
  • [23] Dietary strategies for cardiovascular disease risk factors prevention
    Mazur, Michal
    Przytula, Agata
    Szymanska, Magdalena
    Popiolek-Kalisz, Joanna
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (09)
  • [24] The role of the dietary patterns in the cardiovascular disease risk prevention
    Pelczynska, Marta
    Burak, Weronika
    Krolak, Stanislaw
    Geppert, Adrianna
    Lipczynski, Marcel
    Grzybolowska, Julia
    Kociubinski, Patryk
    JOURNAL OF MEDICAL SCIENCE, 2022, 91 (03):
  • [25] 'Mediterranean' dietary pattern for the primary prevention of cardiovascular disease
    Rees, Karen
    Hartley, Louise
    Flowers, Nadine
    Clarke, Aileen
    Hooper, Lee
    Thorogood, Margaret
    Stranges, Saverio
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (08):
  • [27] Aspirin in the treatment and prevention of cardiovascular disease
    Gaziano, JM
    Skerrett, PJ
    Buring, JE
    HAEMOSTASIS, 2000, 30 : 1 - 13
  • [28] Aspirin in the treatment and prevention of cardiovascular disease
    Hennekens, CH
    ANNUAL REVIEW OF PUBLIC HEALTH, 1997, 18 : 37 - 49
  • [29] Magnesium for the prevention and treatment of cardiovascular disease
    DiNicolantonio, James J.
    Liu, Jing
    O'Keefe, James H.
    OPEN HEART, 2018, 5 (02):
  • [30] EXPERIMENTAL-EVIDENCE FOR DIETARY PREVENTION OF CARDIOVASCULAR-DISEASES
    YAMORI, Y
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1989, 16 (04) : 303 - 307